Tag Archives: takes

GBT takes a page from HIV playbook as it embarks on Oxbryta launch

The sickle cell disease market and patient support around the disease are both in the nascent stages. But Global Blood Therapeutics, a pioneer in the field with recently approved Oxbryta, sees an example to emulate as it embarks on its first launch: HIV. In sickle cell, “there’s been tremendous underinvestment—underinvestment in the science, obviously underinvestment… Read More »

GSK, AstraZeneca rivalry takes center stage at cancer conference

(Reuters) – GlaxoSmithKline and AstraZeneca will each present trial data on a promising new class of drugs against ovarian cancer on Saturday as Britain’s top drugmakers compete to burnish their oncology credentials. FILE PHOTO: The GlaxoSmithKline (GSK) logo is seen on top of GSK Asia House in Singapore, March 21, 2018. REUTERS/Loriene Perera/File Photo They… Read More »